Level Four Advisory Services, LLC Penumbra Inc Transaction History

Level Four Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$240.69 - $338.77 $11,553 - $16,260	48 Added 2.39%	2,054 $496,000
Q2 2023 Jul 10, 2023	BUY	$271.54 - $344.06 $544,709 - $690,184	2,006 New	2,006 $690,000
Q2 2022 Aug 08, 2022	SELL	$116.09 - $227.33 $345,367 - $676,306	-2,975 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$187.51 - $283.98 $246,575 - $373,433	1,315 Added 79.22%	2,975 $661,000
Q4 2021 Feb 11, 2022	BUY	$238.08 - $288.0 $210,938 - $255,168	886 Added 114.47%	1,660 $477,000
Q3 2021 Oct 12, 2021	BUY	$250.72 - $291.24 $194,057 - $225,419	774 New	774 $206,000

380

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $10.4B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Level Four Advisory Services, LLC with notifications on news.